Moderna said Tuesday that it expects to deliver 100 million doses of its Covid-19 vaccine to the U.S. by the end of March.
The company is also moving up the expected delivery of its second 100 million doses to the end of May (from the end of March) as well as its third batch of 100 million doses to the end of July (from the end of September.)
In total, Moderna anticipates being able to deliver 300 million doses by the end of July, as opposed to the end of September.
So far, the biotech company has delivered 45.4 million doses of its Covid-19 vaccine, MRNA-1273, and according to the CDC, 25.5 million of those doses have been administered.
Moderna’s current vaccine doses have lagged behind schedule. But, the biotech company says that the issue is the result of short-term production delays at its contractor Catalent, Inc and that the delays are expected to be resolved. As such, they should not impact production targets.
MNRA shares fell -2.9% in Tuesday’s session, ending the day at $178.53. Nonetheless, the stock has been an extraordinary performer, skyrocketing nearly 900% in the last year.
Moderna’s vaccine requires two doses, two weeks apart.
Please make sure to download and subscribe to my podcast here for TRUTH.